跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38,823 条关于
“cyclin-dependent kinase 4/6”
全部
38,823
临床试验
19,091
药物
6,101
机构
2,572
资讯
11,059
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Significantly Improve Outcomes in Advanced Breast Cancer
11年前
Abemaciclib Shows Promise in ER+/HER2- Advanced Breast Cancer Treatment
去年
FDA Approves Ribociclib for Adjuvant Treatment of Early Breast Cancer
去年
FDA Aligns with Olema on 90mg Palazestrant Dose for Phase 3 Breast Cancer Trials
10年前
Palbociclib Plus Letrozole Approved for First-Line ER+, HER2- Metastatic Breast Cancer
去年
Immutep's Efti Shows Promise in Lung and Head & Neck Cancers, Advances Autoimmune Program
去年
Incyclix Bio's INX-315 Shows Promise in Advanced Breast and Ovarian Cancers
去年
Genentech's Itovebi Combo Demonstrates Overall Survival Benefit in HER2-Negative Breast Cancer
去年
Olema Oncology and Pfizer Launch Phase 1b/2 Trial Combining Palazestrant with Atirmociclib for ER+/HER2- Metastatic Breast Cancer
第 1 页，共 1106 页
上一页
下一页
